The most recent approaches to the initial treatment of respiratory distress syndrome (RDS)- involve non-invasive ventilation (NIV) and less-invasive surfactant (SF) administration (LISA). Combining th

Figshare2023-04-28 更新20

Poractant alfa versus bovine lipid extract surfactant for infants 24+0 to 31+6 weeks gestational age: A randomized controlled trial

新生儿呼吸窘迫综合征

肺表面活性剂临床试验

ObjectivesTo compare the efficacy and safety of poractant alfa and bovine lipid extract surfactant in preterm infants.Study designRandomized, partially-blinded, multicenter trial. Infants ResultsThree

Figshare2017-05-05 更新50

Supplementary Material for: Analgosedation before Less-Invasive Surfactant Administration: A Systematic Review

新生儿呼吸窘迫综合征

微创表面活性物质给药

Background: Surfactant therapy is the cornerstone of respiratory distress syndrome management. “Less-invasive surfactant administration (LISA)” is now recommended for spontaneously breathing preterm i

Figshare2022-02-04 更新20

Lung Ultrasound Score Progress in Neonatal Respiratory Distress Syndrome

资源简介：

相关数据集